Published on
04:18 GMT
Post-Makary, new rare disease framework faces fresh uncertainty
Last month, the FDA held a workshop to discuss implementing its plausible mechanism pathway for individualized therapies, first introduced in November 2025 by Commissioner Marty Makary and Center for Biologics Evaluation and Research Director Vinay Prasad …
Source:
BioSpace
-
Pending
